MX9201637A - Derivados de tiazolidindiona, proceso para su produccion y composicion farmaceutica que los contiene. - Google Patents

Derivados de tiazolidindiona, proceso para su produccion y composicion farmaceutica que los contiene.

Info

Publication number
MX9201637A
MX9201637A MX9201637A MX9201637A MX9201637A MX 9201637 A MX9201637 A MX 9201637A MX 9201637 A MX9201637 A MX 9201637A MX 9201637 A MX9201637 A MX 9201637A MX 9201637 A MX9201637 A MX 9201637A
Authority
MX
Mexico
Prior art keywords
tiazolidindiona
derivatives
production
pharmaceutical composition
general formula
Prior art date
Application number
MX9201637A
Other languages
English (en)
Inventor
Takashi Sohda
Hitoshi Ikeda
John C Greenfield
Jerry R Colca
Edgar N Petzold
Original Assignee
Takeda Chemical Industries Ltd
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13672917&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9201637(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd, Upjohn Co filed Critical Takeda Chemical Industries Ltd
Publication of MX9201637A publication Critical patent/MX9201637A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Graft Or Block Polymers (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Lubricants (AREA)

Abstract

Esta invención describe un derivado de tiazolidindiona de fórmula general (1) (FORMULA 1) en donde X es -CH2- o -CO-, Q es CH3CO-, CH3CH(OR)- o -CH2COOH, cuando X es -CH2-, en donde R es un átomo de hidrógeno o un grupo acilo o Q es CH3CH2-, cuando X es -CO-, una sal farmacéuticamente aceptable del mismo, o una forma estereoisométricamente pura del mismo. El derivado de tiazolidindiona de fórmula general (1) tiene actividades hipoglicémicas e hipolipidémicas.
MX9201637A 1991-04-11 1992-04-09 Derivados de tiazolidindiona, proceso para su produccion y composicion farmaceutica que los contiene. MX9201637A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7883691 1991-04-11

Publications (1)

Publication Number Publication Date
MX9201637A true MX9201637A (es) 1993-08-01

Family

ID=13672917

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9201637A MX9201637A (es) 1991-04-11 1992-04-09 Derivados de tiazolidindiona, proceso para su produccion y composicion farmaceutica que los contiene.

Country Status (19)

Country Link
EP (1) EP0579733B1 (es)
JP (1) JP3176694B2 (es)
KR (1) KR100249988B1 (es)
AT (1) ATE202352T1 (es)
AU (1) AU1743292A (es)
CA (1) CA2106967C (es)
CZ (1) CZ196693A3 (es)
DE (1) DE69231886T2 (es)
DK (1) DK0579733T3 (es)
ES (1) ES2161692T3 (es)
FI (1) FI934426A0 (es)
GR (1) GR3036623T3 (es)
HU (1) HUT68370A (es)
MX (1) MX9201637A (es)
NO (1) NO933615D0 (es)
PT (1) PT100366A (es)
SK (1) SK109993A3 (es)
TW (1) TW209864B (es)
WO (1) WO1992018501A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993022445A1 (en) * 1992-05-05 1993-11-11 The Upjohn Company A process for producing pioglitazone metabolite
TW268952B (es) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
RU2151145C1 (ru) * 1994-04-11 2000-06-20 Санкио Компани Лимитед Промежуточное соединение для получения гетероциклических соединений, обладающих антидиабетической активностью
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5952509A (en) * 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds
CN1168451C (zh) 1997-06-18 2004-09-29 史密丝克莱恩比彻姆有限公司 噻唑烷二酮和磺酰脲组合物在制备治疗糖尿病的药物中的用途
EA007610B1 (ru) 1998-11-12 2006-12-29 Смитклайн Бичам Плс Таблетка с энтеропокрытием, обеспечивающая отсроченное высвобождение
AR023700A1 (es) 1998-11-12 2002-09-04 Smithkline Beecham Plc Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
GB0014969D0 (en) 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
DE20119200U1 (de) 2001-11-27 2003-04-10 Joh. Winklhofer & Söhne GmbH und Co KG, 81369 München Kettenspanner mit mechanischer Verriegelung
US8268352B2 (en) 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
KR100646128B1 (ko) 2005-04-21 2006-11-14 전라옥 ＰＰＡＲγ에 선택적으로 작용하는 테트라하이드로퀴놀린계열 티아졸리딘디온 유도체 및 그 합성방법
EP2001470A2 (en) * 2006-03-16 2008-12-17 Metabolic Solutions Development Company Combination therapies of thiazolidinedione analogues
MX356584B (es) * 2006-03-16 2018-06-05 Metabolic Solutions Dev Co Analogos de tiazolidindiona para el tratamiento de enfermedad mediada por inflamacion metabolica.
PL2001469T3 (pl) 2006-03-16 2012-10-31 Metabolic Solutions Dev Co Llc Analogi tiazolidynodionu
AU2013200104B2 (en) * 2006-03-16 2014-05-15 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2008038359A1 (en) * 2006-09-28 2008-04-03 Daido Kogyo Co., Ltd. Chain tensioner
NZ597381A (en) 2007-09-14 2013-03-28 Metabolic Solutions Dev Co Llc Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
DK2513070T3 (en) 2009-12-15 2018-01-22 Cirius Therapeutics Inc PPAR-sparing thiazolidinedione salts for the treatment of metabolic disorders
WO2011133442A1 (en) * 2010-04-19 2011-10-27 Metabolic Solutions Development Company Novel synthesis for thiazolidinedione compounds
WO2011133441A2 (en) * 2010-04-19 2011-10-27 Metabolic Solutions Development Company Novel synthesis for thiazolidinedione compounds
WO2012021476A1 (en) 2010-08-10 2012-02-16 Metabolic Solutions Development Company, Llc Novel synthesis for thiazolidinedione compounds
RU2594725C2 (ru) * 2010-08-10 2016-08-20 МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи Синтез соединений тиазолидиндиона
US20120094959A1 (en) 2010-10-19 2012-04-19 Bonnie Blazer-Yost Treatment of cystic diseases
US8969581B2 (en) * 2013-03-14 2015-03-03 Deuterx, Llc 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
WO2015109037A1 (en) 2014-01-15 2015-07-23 Deuterx, Llc Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
ES2678046T3 (es) * 2014-04-02 2018-08-08 Minoryx Therapeutics S.L. Derivados de 2,4-tiazolidindiona en el tratamiento de trastornos del sistema nervioso central
WO2016071727A1 (en) 2014-11-04 2016-05-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the prevention and the treatment of rapidly progressive glomerulonephritis
LT3548026T (lt) 2016-12-01 2021-05-25 Minoryx Therapeutics S.L. 5-[[4-[2-[5-(1-hidroksietil)piridin-2-il]etoksi]fenil]metil]-1,3-tiazolidin-2,4-dionas nealkoholinio kepenų suriebėjimo gydymui
EP3559010B1 (en) * 2016-12-23 2022-06-08 Minoryx Therapeutics S.L. Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione and salts thereof
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone
AU2024268104A1 (en) * 2023-05-09 2025-11-27 Minoryx Therapeutics S.L. Polymorphic forms and formulations of leriglitazone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales

Also Published As

Publication number Publication date
FI934426A7 (fi) 1993-10-08
GR3036623T3 (en) 2001-12-31
EP0579733B1 (en) 2001-06-20
FI934426L (fi) 1993-10-08
NO933615L (no) 1993-10-08
JPH0586057A (ja) 1993-04-06
ES2161692T3 (es) 2001-12-16
TW209864B (es) 1993-07-21
CZ196693A3 (en) 1994-05-18
NO933615D0 (no) 1993-10-08
EP0579733A1 (en) 1994-01-26
FI934426A0 (fi) 1993-10-08
PT100366A (pt) 1993-06-30
CA2106967C (en) 2003-12-09
SK109993A3 (en) 1994-12-07
HUT68370A (en) 1995-06-28
CA2106967A1 (en) 1992-10-12
KR100249988B1 (ko) 2000-04-01
AU1743292A (en) 1992-11-17
DE69231886D1 (de) 2001-07-26
ATE202352T1 (de) 2001-07-15
DE69231886T2 (de) 2002-03-28
JP3176694B2 (ja) 2001-06-18
DK0579733T3 (da) 2001-10-15
WO1992018501A1 (en) 1992-10-29

Similar Documents

Publication Publication Date Title
MX9201637A (es) Derivados de tiazolidindiona, proceso para su produccion y composicion farmaceutica que los contiene.
MX9302214A (es) Derivados de taxol y proceso para su preparacion
AR031066A1 (es) Un compuesto que comprende una amida, un proceso para su preparacion, composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
MX9203677A (es) Derivados ciclicos, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
AR006360A1 (es) Derivados de 1,2,3,4-tetrahidronaftaleno substituidos, uso de los mismos para la preparacion de medicamentos y procedimiento para su preparacion.
MY110142A (en) Thiazolidinedione derivatives, their production and use
PT687260E (pt) Processo para a preparacao de 9-desoxotaxanos
NO306930B1 (no) Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel
ATE192446T1 (de) Kondensierte benzoxa-ringverbindung, deren herstellung sowie diese enthaltendes arzneimittel
ES2062486T3 (es) 3-fenilbenzofuran-2-onas.
ES8801618A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
ES2158109T3 (es) Nuevo derivado de indano fusionado y sal del mismo farmaceuticamente aceptable.
MX9100607A (es) Compuesto triciclico novedoso o sales del mismo,metodo para producir el mismo y agente antimicrobiano que lo contiene
MX9301240A (es) Derivados heterociclicos de cetona, condensados, metodo para su produccion y composicion farmaceutica que los contiene.
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
DE68916174D1 (de) Mevalonolactone vom Thienopyridin-Typ.
MX9601635A (es) Derivados de antraciclina.
ES2086442T3 (es) Derivados de fluoroetilcamptotecina.
ECSP941050A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
ES2155091T3 (es) Procedimiento para la produccion de inhibidores de la proteasa del vih.
ES2051955T3 (es) Compuestos azaalifaticos ciclicos con funcion nitroxi, procedimiento para su produccion y medicamentos que contienen estos compuestos.
MX9205921A (es) Derivados de bis(fenil)etano, proceso para su preparacion y composicion farmaceutica que los contiene
BR9914399A (pt) Composto de piridopirazina, processo para sua produção e seu uso
KR910018028A (ko) 15- 데히드록시-16-옥소프로스타글란딘 화합물에 의한 생화학적 치료
AR005866A1 (es) Composicion farmaceutica antioxidante